LUCY RIVILIS: Open Payments
NPI 1225471568 · OLD BRIDGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,137 in 85 payments from 17 companies in 2025. Trend: 2023 $1,464 · 2024 $1,301 · 2025 $1,137
Food & beverage: $1,137
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 18 | $263 |
| ABBVIE INC. | 26 | $233 |
| Novo Nordisk Inc | 10 | $136 |
| Corcept Therapeutics | 5 | $82 |
| Gilead Sciences, Inc. | 4 | $65 |
| Phathom Pharmaceuticals, Inc. | 5 | $59 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Madrigal Pharmaceuticals | 2 | $35 |
| Ardelyx, Inc. | 2 | $33 |
| Merck Sharp & Dohme LLC | 2 | $33 |
Products named: XIFAXAN, VRAYLAR, Korlym, UBRELVY, VOQUEZNA, Wegovy, QULIPTA, REZDIFFRA.
Industry payments across NJ — which companies pay providers there.
